sc002 has been researched along with Neuroblastoma* in 1 studies
1 other study(ies) available for sc002 and Neuroblastoma
| Article | Year |
|---|---|
Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma.
Topics: Child; Humans; Immunoconjugates; Intracellular Signaling Peptides and Proteins; Ligands; Lung Neoplasms; Membrane Proteins; Neuroblastoma; Small Cell Lung Carcinoma | 2022 |